SIFORM: shared informative factor models for integration of multi-platform bioinformatic data
暂无分享,去创建一个
Kim-Anh Do | Jianhua Hu | Xuebei An | K. Do | Jianhua Hu | Xuebei An
[1] Eun Hee Lee,et al. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer. , 2015, International journal of clinical and experimental pathology.
[2] A. Chiappori,et al. Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations. , 2014, Cancer control : journal of the Moffitt Cancer Center.
[3] P. Bonaldo,et al. Collagen VI in cancer and its biological mechanisms. , 2013, Trends in molecular medicine.
[4] Fadlo R Khuri,et al. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. , 2006, Cancer research.
[5] Dawei Song,et al. Clinicopathological significance of E-cadherin and PCNA expression in hunman non-small cell lung cancer , 2008 .
[6] Kenji Eguchi,et al. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma. , 2010, Lung cancer.
[7] Yang Ni,et al. Integrative Bayesian Network Analysis of Genomic Data , 2014, Cancer informatics.
[8] Klaus Beiske,et al. BRAF-mutations in non-small cell lung cancer. , 2014, Lung cancer.
[9] Francesco C Stingo,et al. miRNA–target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer , 2015, Biometrics.
[10] A. Godwin,et al. The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis , 2011, Oncogene.
[11] Kim-Anh Do,et al. DINGO: differential network analysis in genomics , 2015, Bioinform..
[12] Raj Chari,et al. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer , 2010, BMC Systems Biology.
[13] H. Kuwano,et al. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Jun Li,et al. TCPA: a resource for cancer functional proteomics data , 2013, Nature Methods.
[15] D. Schrenk,et al. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. , 1994, Pharmacogenetics.
[16] D W Nebert,et al. Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics. , 2000, European journal of pharmacology.
[17] Ash A. Alizadeh,et al. 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns , 2000, Genome Biology.
[18] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[19] Yuzo Uchida,et al. Clinical implication of cyclin B1 in non-small cell lung cancer. , 2003, Oncology reports.
[20] Nahum Sonenberg,et al. Modulation of 4E-BP1 Function as a Critical Determinant of Enzastaurin-Induced Apoptosis , 2010, Molecular Cancer Therapeutics.
[21] Gang Wu,et al. EGFR mutations in non‐small‐cell lung cancer among smokers and non‐smokers: A meta‐analysis , 2012, Environmental and molecular mutagenesis.
[22] Robert Tibshirani,et al. Collaborative regression. , 2014, Biostatistics.
[23] P. Petronini,et al. Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. , 2014, Biochemical pharmacology.
[24] Sandra A O'Toole,et al. Molecular biology of lung cancer. , 2013, Journal of thoracic disease.
[25] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[26] Jianqing Fan,et al. Nonconcave penalized likelihood with a diverging number of parameters , 2004, math/0406466.
[27] A. Frigessi,et al. Principles and methods of integrative genomic analyses in cancer , 2014, Nature Reviews Cancer.
[28] Alessandro Antonelli,et al. Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma , 2013, International journal of endocrinology.
[29] Hiroshi Okazaki,et al. Never‐smoking nonsmall cell lung cancer as a separate entity , 2008, Cancer.
[30] Leah E Mechanic,et al. Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. , 2010, Carcinogenesis.
[31] R. Sutherland,et al. Expression and prognostic significance of cyclin B1 and cyclin A in non‐small cell lung cancer , 2009, Histopathology.
[32] R. Tibshirani,et al. A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. , 2009, Biostatistics.
[33] D. Hunter,et al. Variable Selection using MM Algorithms. , 2005, Annals of statistics.
[34] Richard S Houlston,et al. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis. , 2009, Lung cancer.
[35] Chris Sander,et al. Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles , 2011, PloS one.
[36] Daniela M Witten,et al. Extensions of Sparse Canonical Correlation Analysis with Applications to Genomic Data , 2009, Statistical applications in genetics and molecular biology.
[37] Jianqing Fan,et al. Variable Selection via Nonconcave Penalized Likelihood and its Oracle Properties , 2001 .
[38] Wei Pan,et al. Network‐Based Penalized Regression With Application to Genomic Data , 2013, Biometrics.
[39] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[40] Yoshihiko Maehara,et al. Non-small cell lung cancer in never smokers as a representative ‘non-smoking-associated lung cancer’: epidemiology and clinical features , 2011, International Journal of Clinical Oncology.
[41] D. Beer,et al. Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer. , 2014, The Journal of surgical research.
[42] Erika Avila-Tang,et al. Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors , 2009, Clinical Cancer Research.
[43] A. Gazdar,et al. Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.
[44] E. Brambilla,et al. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] S. Piantadosi,et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. , 2001, Cancer research.
[46] Yingying Fan,et al. Tuning parameter selection in high dimensional penalized likelihood , 2013, 1605.03321.
[47] Qian Wang,et al. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer , 2015, Oncotarget.
[48] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[49] Benno Schwikowski,et al. Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.
[50] M. Serke. [Lung cancer: targeted therapy]. , 2007 .
[51] A. Chinnaiyan,et al. Integrative analysis of the cancer transcriptome , 2005, Nature Genetics.
[52] Hideki Kawai,et al. Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[53] A. Gingras,et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.
[54] P. Laird,et al. Discovery of multi-dimensional modules by integrative analysis of cancer genomic data , 2012, Nucleic acids research.
[55] Abby C Collier,et al. Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. , 2002, Human reproduction.
[56] Arnoldo Frigessi,et al. BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm305 Gene expression Predicting survival from microarray data—a comparative study , 2022 .
[57] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[58] M. Saif,et al. The Biological Role of PI3K Pathway in Lung Cancer , 2012, Pharmaceuticals.
[59] D. Wheeler,et al. The nuclear epidermal growth factor receptor signaling network and its role in cancer. , 2011, Discovery medicine.
[60] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[61] Liang Dai,et al. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment , 2015, Tumor Biology.
[62] I. Petrache,et al. Overexpression of type VI collagen in neoplastic lung tissues , 2014, Oncology reports.
[63] Kenneth M. Yamada,et al. Fibronectin at a glance , 2002, Journal of Cell Science.
[64] H. Zou. The Adaptive Lasso and Its Oracle Properties , 2006 .
[65] R. Tibshirani,et al. On the “degrees of freedom” of the lasso , 2007, 0712.0881.